Zobrazeno 1 - 10
of 97
pro vyhledávání: '"C. Jan Willem Borleffs"'
Autor:
Pascal R. D. Clephas, Jishnu Malgie, Jeroen Schaap, Stefan Koudstaal, Mireille Emans, Gerard C. M. Linssen, Grytsje A. deBoer, Loek vanHeerebeek, C. Jan Willem Borleffs, Olivier C. Manintveld, Vanessa vanEmpel, Sandra vanWijk, Mieke van denHeuvel, Carlos daFonseca, Kevin Damman, Jan vanRamshorst, Roland vanKimmenade, Arjen R. T. van deVen, René A. Tio, Dennis vanVeghel, Folkert W. Asselbergs, Rudolf A. deBoer, Peter van derMeer, Stephen J. Greene, Hans‐Peter Brunner‐La Rocca, Jasper J. Brugts
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 550-559 (2024)
Abstract Aims Current heart failure (HF) guidelines recommend to prescribe four drug classes in patients with HF with reduced ejection fraction (HFrEF). A clear challenge exists to adequately implement guideline‐directed medical therapy (GDMT) rega
Externí odkaz:
https://doaj.org/article/76fc22140ff146f4acc31d2d5d84e800
Autor:
Toru Kondo, Karola S. Jering, C. Jan Willem Borleffs, Rudolf A. de Boer, Brian L. Claggett, Akshay S. Desai, Dan Dobreanu, Silvio E. Inzucchi, Adrian F. Hernandez, Stefan P. Janssens, Pardeep S. Jhund, Mikhail N. Kosiborod, Carolyn S.P. Lam, Anna Maria Langkilde, Felipe A. Martinez, Magnus Petersson, Pham Nguyen Vinh, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray
Publikováno v:
Circulation, 147(14), 1067-1078. Lippincott Williams & Wilkins
Background: How patient characteristics and outcomes vary according to the duration of heart failure (HF) is unknown in individuals with mildly reduced or preserved ejection fraction. We compared these, and the efficacy and safety of dapagliflozin, a
Autor:
Scott D, Solomon, John J V, McMurray, Brian, Claggett, Rudolf A, de Boer, David, DeMets, Adrian F, Hernandez, Silvio E, Inzucchi, Mikhail N, Kosiborod, Carolyn S P, Lam, Felipe, Martinez, Sanjiv J, Shah, Akshay S, Desai, Pardeep S, Jhund, Jan, Belohlavek, Chern-En, Chiang, C Jan Willem, Borleffs, Josep, Comin-Colet, Dan, Dobreanu, Jaroslaw, Drozdz, James C, Fang, Marco Antonio, Alcocer-Gamba, Waleed, Al Habeeb, Yaling, Han, Jose Walter, Cabrera Honorio, Stefan P, Janssens, Tzvetana, Katova, Masafumi, Kitakaze, Béla, Merkely, Eileen, O'Meara, Jose Francisco Kerr, Saraiva, Sergey N, Tereshchenko, Jorge, Thierer, Muthiah, Vaduganathan, Orly, Vardeny, Subodh, Verma, Vinh Nguyen, Pham, Ulrica, Wilderäng, Natalia, Zaozerska, Erasmus, Bachus, Daniel, Lindholm, Magnus, Petersson, Anna Maria, Langkilde, Minh, Ton
Publikováno v:
New England Journal of Medicine, 387(12), 1089-1098. MASSACHUSETTS MEDICAL SOC
Background: \ud Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ejection fraction of 40% or less. Wheth
Autor:
Shmaila, Saleem-Talib, Vincent J, van Driel, Tanja, Nikolic, Harry, van Wessel, Hellen, Louman, C Jan Willem, Borleffs, Jeroen, van der Heijden, Moniek, Cox, Hemanth, Ramanna
Publikováno v:
Pacing and Clinical Electrophysiology. 45:1248-1254
To evaluate safety of leadless pacemaker implantation through the internal jugular vein in a larger cohort with longer follow-up. Moreover, feasibility of non-apical pacing as well as relation between pacing site and QRS duration were assessed.Eighty
Autor:
Alexander Peikert, Alvin Chandra, Mikhail N. Kosiborod, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Carolyn S. P. Lam, Silvio E. Inzucchi, Felipe A. Martinez, Rudolf A. de Boer, Adrian F. Hernandez, Sanjiv J. Shah, Stefan P. Janssens, Jan Bělohlávek, C. Jan Willem Borleffs, Dan Dobreanu, Anna Maria Langkilde, Olof Bengtsson, Magnus Petersson, John J. V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
Publikováno v:
JAMA Cardiology.
ImportanceDapagliflozin has been shown to improve overall health status based on aggregate summary scores of the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failure (HF) with mildly reduced or preserved ejection fraction en
Autor:
Jasper J Brugts, Sumant P Radhoe, Pascal R D Clephas, Dilan Aydin, Marco W F van Gent, Mariusz K Szymanski, Michiel Rienstra, Mieke H van den Heuvel, Carlos A da Fonseca, Gerard C M Linssen, C Jan Willem Borleffs, Eric Boersma, Folkert W Asselbergs, Arend Mosterd, Hans-Peter Brunner-La Rocca, Rudolf A de Boer, M E Emans, S L M A Beeres, L Heerebeek, C Kirchhof, J Van Ramshorst, R Spee, T Smilde, M Van Eck, E Kaplan, R Hazeleger, R Tukkie, M Feenema, W Kok, V Van Halm, M L Handoko, R Van Kimmenade, M Post, N Van Mieghem, O C Manintveld
Publikováno v:
The Lancet.
Autor:
Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink, Sean P. Collins, Mikhail Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E. Nassif, Mitchell A. Psotka, Jasper Tromp, C. Jan Willem Borleffs, Changsheng Ma, Joseph Comin-Colet, Michael Fu, Stefan P. Janssens, Robert G. Kiss, Robert J. Mentz, Yasushi Sakata, Henrik Schirmer, Morten Schou, P. Christian Schulze, Lenka Spinarova, Maurizio Volterrani, Jerzy K. Wranicz, Uwe Zeymer, Shelley Zieroth, Martina Brueckmann, Jonathan P. Blatchford, Afshin Salsali, Piotr Ponikowski
Publikováno v:
Nature Medicine, 28(3), 568-574. Nature Publishing Group
Voors, A A, Angermann, C E, Teerlink, J R, Collins, S P, Kosiborod, M, Biegus, J, Ferreira, J P, Nassif, M E, Psotka, M A, Tromp, J, Borleffs, C J W, Ma, C, Comin-Colet, J, Fu, M, Janssens, S P, Kiss, R G, Mentz, R J, Sakata, Y, Schirmer, H, Schou, M, Schulze, P C, Spinarova, L, Volterrani, M, Wranicz, J K, Zeymer, U, Zieroth, S, Brueckmann, M, Blatchford, J P, Salsali, A & Ponikowski, P 2022, ' The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure : a multinational randomized trial ', Nature Medicine, vol. 28, no. 3, pp. 568-574 . https://doi.org/10.1038/s41591-021-01659-1
Voors, A A, Angermann, C E, Teerlink, J R, Collins, S P, Kosiborod, M, Biegus, J, Ferreira, J P, Nassif, M E, Psotka, M A, Tromp, J, Borleffs, C J W, Ma, C, Comin-Colet, J, Fu, M, Janssens, S P, Kiss, R G, Mentz, R J, Sakata, Y, Schirmer, H, Schou, M, Schulze, P C, Spinarova, L, Volterrani, M, Wranicz, J K, Zeymer, U, Zieroth, S, Brueckmann, M, Blatchford, J P, Salsali, A & Ponikowski, P 2022, ' The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure : a multinational randomized trial ', Nature Medicine, vol. 28, no. 3, pp. 568-574 . https://doi.org/10.1038/s41591-021-01659-1
The sodium–glucose cotransporter 2 inhibitor empagliflozin reduces the risk of cardiovascular death or heart failure hospitalization in patients with chronic heart failure, but whether empagliflozin also improves clinical outcomes when initiated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba2772007a16a0ae82a7d40c0345bc5f
https://research.rug.nl/en/publications/70f50ca3-ed7b-44eb-9f1b-e25050dbf5cd
https://research.rug.nl/en/publications/70f50ca3-ed7b-44eb-9f1b-e25050dbf5cd
Autor:
Scott D. Solomon, Muthiah Vaduganathan, Brian L. Claggett, Rudolf A. de Boer, David DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Carolyn S.P. Lam, Felipe Martinez, Sanjiv J. Shah, Jan Belohlavek, Chern-En Chiang, C. Jan Willem Borleffs, Josep Comin-Colet, Dan Dobreanu, Jaroslaw Drozdz, James C. Fang, Marco Antonio Alcocer Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan P. Janssens, Tsvetana Katova, Masafumi Kitakaze, Bela Merkely, Eileen O’Meara, Jose Francisco Kerr Saraiva, Sergey N. Tereschenko, Jorge Thierer, Orly Vardeny, Subodh Verma, Pham Nguyen Vinh, Ulrica Wilderäng, Natalia Zaozerska, Daniel Lindholm, Magnus Petersson, John J.V. McMurray
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
OBJECTIVES This report describes the baseline clinical profiles and management of DELIVER (Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure) trial participants and how these compare with those i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f76827717fa9c08b946457bb42346d10
http://hdl.handle.net/2445/185580
http://hdl.handle.net/2445/185580
Autor:
C. Jan Willem Borleffs, Hemanth Ramanna, Sevasti-Maria Chaldoupi, Vincent J. van Driel, Harry van Wessel, Tanja Nikolic, Shmaila Saleem-Talib
Publikováno v:
Pacing and Clinical Electrophysiology
Background Leadless pacing is generally performed from a femoral approach. However, the femoral route is not always available. Until now, data regarding implantation using a jugular approach other than a single‐case report were lacking. Methods The
Mortality differences in acute myocardial infarction patients in the Netherlands: The weekend-effect
Autor:
C. Jan Willem Borleffs, Hoi W. Wu, Judith A. van Erkelens, Suzanne C. Cannegieter, D.C. Eindhoven, Stijn W.F. Kremer, Martin J. Schalij
Publikováno v:
American Heart Journal, 205, 70-76
Several studies have shown that patients admitted with an acute myocardial infarction during the weekends have a higher mortality rate than those admitted during weekdays, possibly attributable to less trained personnel available and a lower use of m